Proteome analysis of human Wharton's jelly cells during in vitro expansion

Abstract

BackgroundThe human umbilical cord contains mucoid connective tissue and fibroblast-like cells. These cells named Wharton's jelly cells, (WJCs) display properties similar to mesenchymal stem cells therefore representing a rich source of primitive cells to be potentially used in regenerative medicine.ResultsTo better understand their self-renewal and potential in vitro expansion capacity, a reference 2D map was constructed as a proteomic data set. 158 unique proteins were identified. More than 30% of these proteins belong to cytoskeleton compartment. We also found that several proteins including Shootin1, Adenylate kinase 5 isoenzyme and Plasminogen activator-inhibitor 2 are no longer expressed after the 2nd passage of in vitro replication. This indicates that the proliferative potency of these cells is reduced after the initial stage of in vitro growing. At the end of cellular culturing, new synthesized proteins, including, ERO1-like protein alpha, Aspartyl-tRNA synthetase and Prolyl-4-hydroxylase were identified. It is suggested that these new synthesized proteins are involved in the impairment of cellular surviving during replication and differentiation time.ConclusionsOur work represents an essential step towards gaining knowledge of the molecular properties of WJCs so as to better understand their possible use in the field of cell therapy and regenerative medicine.

Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cells

“…After ELF-MF treatment, in three different exposure times (5, 10, and 15 days, respectively) SH-SY5Y cells were harvested and resolved by 2D-PAGE according to procedures described previously [Angelucci et al, 2010]. In order to create a master gel representative of all conditions analyzed, 3 different gel runs for each control and treated samples were performed and then subjected to image analysis with Image Master 2D platinum software (GE Healthcare formerly Amersham Biotech, Uppsala, Sweden).…”

Diabetes Mellitus During Pregnancy Interferes with the Biological Characteristics of Wharton's Jelly Mesenchymal Stem Cells

“…Cells were cultured exchanging the medium every 3-4 days until reaching confluence. Adherent cells were detached with 0.05 % trypsin-EDTA, counted by Trypan Blue exclusion test, and re-seeded at 3000 cells/cm 2 to reach the 90 % of confluence after 3-4 population doublings [30].…”

Umbilical cord as a mesenchymal stem cell source for treating joint pathologies

“…These results could lead to a new reproductive therapy utilizing human umbilical cord MSCs as well as provide a novel in vitro model for investigating the molecular mechanisms regulating development of the mammalian germ cell lineage [37] . Proteomic analyses of human MSCs from Wharton' s jelly during in vitro expansion have demonstrated their potential capacity for self-renewal and in vitro expansion [38] . More than 30% of 158 proteins identified by these analyses belong to the cytoskeleton complex.…”

“…However, several proteins were no longer expressed after the 2nd in vitro passage, suggesting the proliferative potency of these cells was reduced after the initial in vitro stage. This important study provides an essential step for gaining an understanding of the molecular properties of Wharton's jelly cells [38] . Obstetric parameters, including the gender of the baby, birth weight, the age of the mother at delivery, gestational stage at parturition and mode of delivery were examined by Penolazzi et al [39] who found that osteoblastic potential was not influenced by the baby's gender and mode of delivery.…”